Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 7, 2015, Pages 1241-1248

  Russo, V ^a   Di Meo, F ^a   Rago, A ^a   Papa, A A ^a   Molino, A ^b   Mosella, M ^b   Politano, L ^a   Russo, M G ^a   Nigro, G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Arrhythmias; Atrial fibrillation; Electrocardiogram; Myotonic dystrophy; P wave dispersion; P wave duration

Indexed keywords

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIAC PATIENT; COLOR ULTRASOUND FLOWMETRY; COMPARATIVE STUDY; CONTROLLED STUDY; DUAL CHAMBER PACEMAKER; FEMALE; HEART ATRIUM CONDUCTION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MYOTONIC DYSTROPHY; NON INVASIVE PROCEDURE; P WAVE; P WAVE DISPERSION; P WAVE DURATION; PACEMAKER IMPLANTATION; PAROXYSMAL ATRIAL FIBRILLATION; PR INTERVAL; PREDICTIVE VALUE; QRS COMPLEX; RISK FACTOR; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; COHORT ANALYSIS; CONGENITAL MALFORMATION; ELECTROCARDIOGRAPHY; HEART MUSCLE CONDUCTION SYSTEM; PATHOPHYSIOLOGY; TRENDS;

ADULT; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY;

EID: 84942254098     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. PHILLIPS MF, HARPER PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997;33:13-22.
2. WALTON JN. Clinical examination of the neuromuscular system. In: Sir JohnWalton (ed.). Disorders of Voluntary Muscle. London: Churchill Livingstone; 1981.
3. HARLEY HG, BROOK JD, RUNDLE SA, CROW S, REARDON W, BUCKLER AJ, HARPER PS, HOUSMAN DE, SHAW DJ. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992;355:545-546.
4. NIGRO G, PAPA AA, POLITANO L. The heart and cardiac pacing in Steinert disease. Acta Myol. 2012;31:110-116.
5. NGUYEN HH, WOLFE JT III, HOLMES DR JR, EDWARDS WD. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol 1988;11:662-671.
6. GREGORATOS G, ABRAMS J, EPSTEIN AE, FREEDMAN RA, HAYES DL, HLATKY MA KERBER RE, NACCARELLI GV, SCHOENFELD MH, SILKA MJ, WINTERS SL, GIBBONS RJ, ANTMAN EM, ALPERT JS, GREGORATOS G, HIRATZKA LF, FAXON DP, JACOBS AK, FUSTER V, SMITH SC JR. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American college of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-2161.
7. OLOFSSON BO, FORSBERG H, ANDERSSON S, BJERLE P, HENRIKSSON A, WEDIN I. Electrocardiographic findings in myotonic dystrophy. Br Heart J 1988;59:47-52.
8. PELARGONIO G, DELLO RUSSO A, SANNA T, DE MARTINO G, BELLOCCI F. Myotonic dystrophy and the heart. Heart 2002;88:665-670.
9. GIALAFOS JE, DI LAVERI S PE, GIALAFOS EJ, ANDRIKOPOULOS GK, RICHTER DJ, TRIPOSKIADIS F. Pwave dispersion: a valuable electrocardiographic marker for the prediction of paroxysmal lone atrial fibrillation. Ann Noninvasive Electrocardiol 1999;4:39-45.
10. DILAVERIS P, GIALAFOS EJ, SIDERIS SK, THEOPISTOU AM, ANDRIKOPOULOS GK, KYRIAKIDIS M, GIALAFOS JE, TOUTOUZAS PK. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998;135:733-738.
11. PLATONOV PG, CARLSON J, INGEMANSSON MP, ROIJER A, HANSSON A, CHIREIKIN LV, OLSSON SB. Detection of inter-atrial conduction defects with unfiltered signalaveraged P-wave ECG in patients with lone atrial fibrillation. Europace 2000;2:32-41.
12. DILAVERIS PE, ANDRIKOPOULOS GK, METAXAS G, RICHTER DJ, AVGEROPOULOU CK, ANDROULAKIS AM, GIALAFOS EJ, MICHAELIDES AP, TOUTOUZAS PK, GIALAFOS JE. Effects of ischemia on P wave dispersion and maximum P wave duration during spontaneous anginal episodes. Pacing Clin Electrophysiol 1999;22:1640-1617.
13. BREMBILLA-PERROT B, SCHWARTZ J, HUTTIN O, FRIKHA Z, SELLAL JM, SADOUL N, BLANGY H, OLIVIER A, LOUIS S, KAMINSKY P. Atrial flutter or fibrillation is the most frequent and life-threatening arrhythmia in myotonic dystrophy. Pacing Clin Electrophysiol 2014;37:329-335.
14. RUSSO V, RAGO A, PAPA AA, POLITANO L, GOLINO P, RUSSO MG, CALABRÒ R, NIGRO G. Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients? Kardiol Pol 2013;71:1147-1153.
15. NIGRO G, RUSSO V, VERGARA P, D'ANDREA A, DI GREGORIO G, POLITANO L, NIGRO G, CALABRÒ R. Optimal site for atrial lead implantation in myotonic dystrophy patients. The role of Bachmann's bundle stimulation. PACE 2008;31:1463-1466.
16. NIGRO G, RUSSO V, POLITANO L, DELLA CIOPPA N, RAGO A, ARENA G, PAPA AA, DELLI PAOLI L, DE CHIARA A, RUSSO MG, GOLINO P, CALABRÒ R. Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? a 12 months follow-up study. Europace 2010;12:1219-1222.
17. RUSSO V, NIGRO G, ANTONIO PAPA A, RAGO A, DI MEO F, CRISTIANO A, MOLINO A, CALABRÒ R, GIOVANNA RUSSO M, POLITANO L. Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement. Acta Myol 2014;33:94-99.
18. RUSSO V, RAGO A, POLITANO L, DELLA CIOPPA N, RUSSO MG, GOLINO P, CALABRÒ R, NIGRO G. The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, singlebind cross over study. Europace 2012;14:486-489.
19. NIGRO G, RUSSO V, POLITANO L, DELLA CIOPPA N, MANFREDI D, CHIANESE R, DE CHIARA A, RAGO A, ARENA G, PALLADINO A, CALABRÒ R. Right atrial appendage versus Bachmann's bundle stimulation: a two year comparative study of electrical parameters in myotonic dystrophy type 1 patients. PACE 2009;32:1192-1197.
20. NIGRO G, RUSSO V, RAGO A, PAPA AA, PALLADINO A, POLITAN L. Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study Acta Myol 2012;31:139-143.
21. RUSSO V, RAGO A, POLITANO L, DELLA CIOPPA N, RUSSO MG, GOLINO P, CALABRÒ R, NIGRO G. The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. Europace 2012;14:486-489.
22. RUSSO V, NIGRO G, RAGO A, ANTONIO PAPA A, PROIETTI R, DELLA CIOPPA N, CRISTIANO A, PALLADINO A, CALABRÒ R, POLITANO L. Atrial fibrillation burden in myotonic dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up. Acta Myol 2013;32:142-147.
23. PETRI H, WITTING N, ERSBØLL MK, SAJADIEH A, DUNØ M, HELWEG-LAR SEN S, VISSING J, KØBER L, BUNDGAARD H. High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: A cross-sectional study. Int J Cardiol 2014;174:31-36.
24. GROH VJ, GROH MR, SAHA C, KINCAID JC, SIMMONS Z, CIAFALONI E, POURMAND R, OTTEN RF, BHAKTA D, NAIR GV, MARASHDEH MM, ZIPES DP, PASCUZZI RM. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008;358:2688-2697.
25. MELACINI P, VILLANOVA C, MENEGAZZO E, NOVELLI G, DANIELI G, RIZZOLI G, FASOLI G, ANGELINI C, BUJA G, MIORELLI M, DALLA PICCOLA B, DALLA VOLTA S. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol 1995;25:239-245.
26. JASPERT A, FAHSOLD R, GREHL, CLAUS D. Myotonic dystrophycorrelation of clinical symptoms with the size of the CTG trinucleotide repeat. J Neurol 1995;242:99-104.
27. RUSSO V, AMMENDOLA E, DE CRESCENZO I, DOCIMO L, SANTANGELO L, CALABRÒ R. Severe obesity and Pwave dispersion: the effect of surgically induced weight loss. Obes Surg 2008;18:90-96.
28. SENEN K, TURHAN H, RIZA ERBAY A, BASAR N, SAATCI YASAR A, SAHIN O, YETKIN E. P-wave duration and Pwave dispersion in patients with dilated cardiomyopathy. Eur J Heart Fail. 2004;6:567-569.
29. BAYKAN M, CELIK S, ERDÖL C, DURMUŞ I, OREM C, KUÇUKOSMANOGLU M, YILMAZ R. Effects of P-wave dispersion on atrial fibrillation in patients with acute anterior wall myocardial infarction. Ann Noninvasive Electrocardiol 2003;8:101-106.
30. RUSSO V, RAGO A, PANNONE B, DI MEO F, PAPA AA, MAYER MC, SPASIANO A, RUSSO MG, GOLINO P, CALABRÒ R, NIGRO G. Early electrocardiographic evaluation of atrial fibrillation risk in beta-thalassemia major patients. Int J Hematol 2011;93:446-451.
31. RUSSO V, RAGO A, PANNONE B, PAPA AA, MAYER MC, SPASIANO A, CALABRÒ R, RUSSO MG, NIGRO G. Atrial fibrillation and beta thalassemia major: the predictive role of the 12-lead electrocardiogram analysis. Indian Pacing Electrophysiol J 2014;14:121-132.
32. RUSSO V, RAGO A, PALLADINO A, PAPA AA, DI MEO F, DELLA CIOPPA N, GOLINO P, RUSSO MG, CALABRÒ R, POLITANO L, NIGRO G. P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. J Investig Med 2011;59:1151-1154.
33. MÖRNER S, LINDQVIST P, MELLBERG C, OLOFSSON BO, BACKMAN C, HENEIN M, LUNDBLAD D, FORSBERG H. Profound cardiac conduction delay predicts mortality in myotonic dystrophy type 1. Journal of internal medicine J Intern Med 2010;268:59-65.
34. MERX W, YOON MS, HAN J. The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation. Am Heart J 1977;94:603-610.
35. KUO CS, MUNAKATA K, REDDY CP, SURAWICZ B. Characteristics and possible mechanisms of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 1983;67:1356-1357.
36. SANTANGELO L, AMMENDOLA E, RUSSO V, CAVALLARO C, VECCHIONE F, GAROFALO S, D'ONOFRIO A, CALABRÒ R. Influence of biventricular pacing on myocardial dispersion of repolarization in dilated cardiomyopathy patients. Europace 2006;8:502-505.
37. SANTANGELO L, AMMENDOLA E, RUSSO V, CAVALLARO C, SECCHIONE F, GAROFANO S, D'ONOFRIO A, CALABRO R. Relationship between transmural dispersion of repolarization, Tpeak-Tend interval and ventricular arrhythmias: Reply. Europace 2007;9:61.
38. RUSSO V, AMMENDOLA E, DE CRESCENZO I, RICCIARDI D, CAPUANO P, TOPATINO A, DOCIMO L, SANTANGELO L, CALABRÒ R. Effect of weight loss following bariatric surgery on myocardial dispersion of repolarization in morbidly obese patients. Obes Surg 2007;17:857-865.
39. NIGRO G, RUSSO V, DI SALVO G, DE CRESCENZO I, RAGO A, PERRONE L, GOLINO P, RUSSO MG, CALABRÒ R. Increased heterogenity of ventricular repolarization in obese nonhypertensive children. Pacing Clin Electrophysiol 2010;33:1533-1539.
40. RUSSO V, RAGO A, PANNONE B, PAPA AA, DI MEO F, MAYER MC, SPASIANO A, RUSSO MG, GOLINO P, CALABRÒ R, NIGRO G. Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death. Eur J Haematol 2011;86:324-331.
41. NIGRO G, RUSSO V, RAGO A, PAPA AA, CIOPPA ND, DI MEO F, CORCIONE A, CAIANIELLO G, RUSSO MG, CALABRÒ R. Heterogeneity of ventricular repolarization in newborns with severe aortic coarctation. Pediatr Cardiol 2012;33:302-306.
42. NIGRO G, RUSSO V, RAGO A, PAPA AA, DELLA CIOPPA N, SCARPATI C, PALLADINO T, CORCIONE A, CAIANIELLO G, RUSSO MG. The effect of aortic coarctation surgical repair on QTc and JTc dispersion in severe aortic coarctation newborns: a short-term followup study. Physiol Res 2014;63:27-33.
43. RUSSO V, RAGO A, POLITANO L, PAPA AA, DI MEO F, RUSSO MG, GOLINO P, CALABRÒ R, NIGRO G. Increased dispersion of ventricular repolarization in Emery Dreifuss muscular dystrophy patients. Med Sci Monit 2012;18:CR643-647.
44. RUSSO V, RAGO A, D'ANDREA A, POLITANO L, NIGRO G. Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. Anadolu Kardiyol Derg 2012;12:517-519.
45. NIGRO G, RUSSO V, RAGO A, PAPA AA, CARBONE N, MARCHEL M, PALLADINO A, HAUSMANOWA PETRUSEWICZ I, RUSSO MG, POLITANO L. Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. Kardiol Pol 2012;70:1154-1159.
46. NIGRO G, RUSSO V, VENTRIGLIA VM, DELLA CIOPPA N, PALLADINO A, NIGRO V, CALABRÒ R, NIGRO G, POLITANO L. Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery Dreifuss muscular dystrophy. Neuromuscular Dis 2010;20:174-177.
47. RUSSO V, RAGO A, ANTONIO PAPA A, NIGRO G. Cardiac resynchronization improves heart failure in one patient with Myotonic Dystrophy type 1. A case report. Acta Myol 2012;31:154-155.
48. PARK KM, SHIN KJ, KIM SE, PARK J, HA SY, KIM BJ. Prolonged corrected QT interval in patients with myotonic dystrophy type 1. J Clin Neurol 2013;9:186-191.
49. MAGRÌ D, PICCIRILLO G, BUCCI E, PIGNATELLI G, CAUTI FM, MORINO S, LATINO P, SANTINI D, MARRARA F, VOLPE M, ANTONINI G, TESTA M. Increased temporal dispersion of myocardial repolarization in myotonic dystrophy type 1: beyond the cardiac conduction system. Int J Cardiol 2012;156:259-264.
50. NIGRO G, RUSSO V, DE CHIARA A, RAGO A, DELLA CIOPPA N, ARENA G, CHIANESE R, MANFREDI D, CALABRÒ R. AUTONOMIC NERVOUS SYSTEM MODULATION before the onset of sustained atrioventricular nodal reentry tachycardia. Ann Noninvasive Electrocardiol 2010;15:49-55.
51. RUSSO V, DE CRESCENZO I, AMMENDOLA E, SANTANGELO L, CALABRÒ R. Sympathovagal balance analysis in idiopathic postural orthostatic tachycardia syndrome. Acta Biomed 2007;78:133-138.
52. RUSSO V, NIGRO G, CALABRÒ R. Heart rate variability, obesity and bariatric induced weight loss: the importance of selection criteria. Metab Clin Exp 2008;57:1622-1624.
53. RUSSO V, NIGRO G, DE CHIARA A, RAGO A, CALABRÒ R. The impact of selection criteria of obese patients on evaluation of heart rate variability following bariatric surgery weight loss. Letter to Editor. Obesity Surgery 2009;19:397-398.
54. AMMENDOLA E, RUSSO V, POLITANO L, SANTANGELO L, CALABRÒ R. Is heart rate variability (HRV) a valid parameter to predict sudden death in Becker muscular dystrophy patients? Heart 2006;92:1686-1687.
55. DUCCESCHI V, NIGRO GE, SARUBBI B, COMI LI, POLITANO L, PETRETTA VR, NARDI S, BRIGLIA N, SANTANGELO L, NIGRO G, IACONO A. Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy. Intern J Cardiol 1997;59:275-279.
56. POLITANO L, PALLADINO A, NIGRO G, SCUTIFERO M, COZZA V. Usefulness of heart rate variability as a predictor of sudden cardiac death in muscular dystrophies. Acta Myol 2008;27:114-22.
57. INOUE K, OGATA H, MATSUI M, HAYANO J, MIYAKE S, KUMASHIRO M, KUNO M, TOKONAMI F, AII H, AKATSU J, ET AL. Assessment of autonomic function in myotonic dystrophy by spectral analysis of heart-rate variability. J Auton Nerv Syst 1995;55:131-134.
58. HARDIN BA, LOWE MR, BHAKTA D, GROH WJ. Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1. Ann Noninvasive Electrocardiol. 2003;8:227-232.
59. RUSSO V, NIGRO G, PAPA AA, RAGO A, DELLA CIOPPA N, CRISTIANO A, RUSSO MG. Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1. Acta Myol 2014;33:104-106.
60. RAKOCEVI-STOJANOVI V, MILOVANOVI B, IVI N, ILLE T, MARJANOVIC I, STEVI Z, PAVLOVI S, LAVRNI D. Cardiac autonomic nervous system in patients with myotonic dystrophy type 1. Acta Myol 2007;26:112-114.
61. FREGONEZI G, ARAÚJO T, DOURADO JUNIOR ME, FEREZINI J, SILVA E, RESQUETI V. Heart rate variability in myotonic dystrophy type 1 patients. Arq Bras Cardiol 2012;98:353-360.
62. KARAPINAR H, ACAR G, KIRMA C, KAYA Z, KARAVELIOGLU Y, KUCUKDURMAZ Z, ESEN O, ALIZADE E, DASLI T, SIRMA D, ESEN AM. Delayed right atrial lateral electromechanical coupling relative to the septal one can be associated with paroxysmal atrial fibrillation. Eur Rev Med Pharmacol Sci 2013;17:2172-2178.
63. RUSSO V, RAGO A, DI MEO F, PAPA AA, CIARDIELLO C, CRISTIANO A, CALABRÒ R, RUSSO MG, NIGRO G. Atrial Septal Aneurysms and Supraventricular Arrhythmias: The Role of Atrial Electromechanical Delay. Echocardiography. 2015 Mar. 3. doi: 10.1111/echo.12908.
64. TANG B, ZHANG H, JIANG L. The correlation betweenn the mouth diameter of left atrial appendage and stroke risk score in patients with atrial fibrillation. Eur Rev Med Pharmacol Sci. 2015 Mar; 19(5):790-4.
65. PROIETTI R, JOZA J, ARENSI A, LEVI M, RUSSO V, TZIKAS A, DANNA P, SAGONE A, VIECCA M, ESSEBAG V. Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials. Med Devices (Auckl) 2015;8:103-114. doi: 10.2147/MDER. S70672.eCollection 2015. Review.
66. DANNA P, PROIETTI R, SAGONE A, ARENSI A, VIECCA M, RAGO A, RUSSO V. Does left atrial appendage closure with a cardiac plug system reduce the stroke risk in nonvalvular atrial fibrillation patients? A single-center case series. Pacing Clin Electrophysiol 2013;36:347-353.